Blocking 17β‐hydroxysteroid dehydrogenase type 1 in endometrial cancer: a potential novel endocrine therapeutic approach

Publisher： John Wiley & Sons Inc

E-ISSN： 1555-2039|244|2|203-214

ISSN： 0022-3417

Source： THE JOURNAL OF PATHOLOGY, Vol.244, Iss.2, 2018-02, pp. : 203-214

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

UVB induces epidermal 11β‐hydroxysteroid dehydrogenase type 1 activity in vivo

By  

EXPERIMENTAL DERMATOLOGY (ELECTRONIC), Vol. 24, Iss. 5, 2015-05 ,pp. : 370-376

John Wiley & Sons Inc

Access to resources Recommend Favorite

Gender Change in 46,XY Persons with 5α-Reductase-2 Deficiency and 17β-Hydroxysteroid Dehydrogenase-3 Deficiency

By Cohen-Kettenis Peggy  

Archives of Sexual Behavior, Vol. 34, Iss. 4, 2005-08 ,pp. : 399-410

Springer Publishing Company

Access to resources Recommend Favorite

Continuous inhibition of 11β‐hydroxysteroid dehydrogenase type I in adipose tissue leads to tachyphylaxis in humans and rats but not in mice

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 20, 2015-10 ,pp. : 4806-4816

John Wiley & Sons Inc

Access to resources Recommend Favorite

17-Beta-Hydroxysteroid Dehydrogenase in Human Breast and Endometrial Carcinoma

By  

Oncology, Vol. 59, Iss. 1, 2000-11 ,pp. : 5-12

Karger

Access to resources Recommend Favorite

Macrolides increase the expression of 11β‐hydroxysteroid dehydrogenase 1 in human sinonasal epithelium, contributing to glucocorticoid activation in sinonasal mucosa

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 21, 2015-11 ,pp. : 5083-5095

John Wiley & Sons Inc

Access to resources Recommend Favorite